AzTrials
AzTrials

Right Ventricular FunctionBAROLONCT07632027

Bedside Assessment of Right Ventricular Output Lying in Prone Or Supine

A study testing Prone position in people with Right Ventricular Function and Prone Position, run by Sahlgrenska University Hospital at 1 site in Sweden.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

Right ventricular failure (RVF) is a common complication to cardiac surgery, which is associated to mortality, kidney failure, stroke, prolonged mechanical ventilation and ICU stay. The right ventricle is particularly vulnerable to an increased afterload. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Prone position
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteSweden
Study dates
Oct 2026to Oct 2029
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Scheduled for cardiac surgery using cardiopulmonary bypass

Who cannot join

  • BMI >40
  • Emergency surgery
  • Severe pulmonary disease
  • Haemodynamic instability requiring Norepinephrine >0.5mcg/kg/min
  • Intracardiac shunt
  • Severe (or worse) tricuspid regurgitation
  • Any condition which, in the judgement of the investigator, might increase the risk to the patient

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Viktor Erbring, MD contact

+46706456664

viktor.erbring@vgregion.se

Per Persson, MD, PhD contact

+46736467042

per.persson@vgregion.se

Sweden1 site
  • Cardiothoracic Intensive Care Unit

    Gothenburg, 41345

    Viktor Erbring, MD, +46706456664, viktor.erbring@vgregion.se

Other trials in Sweden

About this study

Official title: Bedside Assessment of Right Ventricular Output Lying in Prone Or Supine (the BAROLO Study) Hemodynamic Changes Due to Prone Position in Patients After Cardiac Surgery - a Prospective Randomized Controlled Trial Evaluating the Effect of Prone Position on Right Heart Function

Right ventricular failure (RVF) is a common complication to cardiac surgery, which is associated to mortality, kidney failure, stroke, prolonged mechanical ventilation and ICU stay. The right ventricle is particularly vulnerable to an increased afterload. By increasing pulmonary vascular resistance (PVR), atelectasis might mitigate a negative effect on the right ventricle.

Recruitment maneuvers have been shown to resolve atelectasis and improve hemodynamics by increasing cardiac output and lowering PVR. However these maneuvers transiently raise airway pressures, which in turn increases right ventricular afterload, a situation often poorly tolerated by patients with RVF.

Read more

Prone position is used in patients with respiratory failure and has been shown to decrease mortality in patients with ARDS. Prone position decreases atelectasis and moves ventilation dorsally. In ARDS it also seems to mediate beneficial hemodynamic effects such as an increase in cardiac output and a decrease in PVR.

The investigators hypothesis is that prone position early after cardiac surgery will increase cardiac output by recruitment of atelectasis and thereby decrease PVR.

Read the detailed description

Recruitment and consent:

Patients will be screened for participation no later than the day before surgery. Potential participants will be given written and verbal information regarding the study and time to ask questions and consider their participation.

Randomization:

After end of surgery, at baseline in the ICU, patients will be randomly allocated (1:1 ratio) to supine position and prone position. Block randomization with variable block sizes will be performed with sequentially numbered, opaque, sealed envelopes. All performed by Statistiska konsultgruppen. Patient stratification according to cardiac index at end-surgery will be performed to ensure similar allocation of patients with cardiac index <2.2 L/min/m2 in each group. The investigator who enrolls study participants will not have access to the random allocation sequence.

Sample Size:

Based on previous studies of cardiac surgery or prone position an a priori sample size calculation was performed using a two-sample t-test comparison of means, with equally sized independent groups. With intention to detect at least a 20% difference in cardiac index in the intervention group and with 80% power, 0.05α, estimated mean CI 2.6(0.9 SD) in control group, and CI 3.2(0.9 SD) in the prone group, the estimated sample size was n=70, divided in 2 equally large groups. As patients intermittently require recurring surgery due to i.e. bleeding, patients might be excluded after inclusion. Enrolment continues until 70 participants have completed the entire study protocol.

Interim analysis:

Given uncertainty regarding expected baseline cardiac index and its standard deviation in the study population, an interim sample size reassessment will be performed after inclusion of 40% of the planned sample (n=28). The interim analysis will be limited to re-estimation of mean and standard deviation of baseline cardiac index, and will not assess treatment effects. If the observed assumptions differ substantially from those used in the original sample size calculation, the required sample size may be adjusted to preserve the planned statistical power of the study.

Description of method:

In included patients, anesthesia will be performed with Propofol, Fentanyl and Sevoflurane. As per clinical routine patients will have a central venous catheter, 1-2 arterial catheters, TEE probe and endotracheal tube inserted. Study participants will also get a pulmonary artery catheter (PAC) inserted prior to surgery to facilitate measurement of cardiac output using thermodilution and PVR. Body surface area is calculated using the Mosteller formula.

During surgery, after CPB is weaned, the attending anaesthesiologist is instructed to refrain from additional recruitment maneuvers and a PEEP >8 cmH2O. Unless FiO2 is >80% to maintain adequate oxygenation of the patient or the anaesthesiologist deems it necessary.

When surgery is finished, the patient will be moved to the Thoracic ICU. Ventilation performed with a Maquet Servo-U (Getinge, SE) is set to volume control, tidal volumes of 6 ml/kg IBW with a respiratory rate of 12-18 and PEEP 8 cmH2O. Data collection occurs in all patients in supine position (0). Hereafter the study group is turned to prone while the control group remains in supine position.

60 minutes after proning data is again collected (t1), whereafter a recruitment maneuver is performed by gradually increasing PEEP during 2,5 minutes in 6 steps to 20 cmH2O during. After 30 seconds PEEP is decreased in 6 steps during 2,5 minutes to reach PEEP 8 cmH2O. Data is collected after the recruitment maneuver (t2) and one hour after (t3), adding up to a total of 2 hours and 15 minutes in supine or prone position. The patients in prone position are turned to supine position and the last data collection occurs (t4). In total 5 time points for data collection. Postoperative care will now continue as per routine care. Patients will be extubated as soon as possible according to clinical routine and eventually discharged from the ICU.

Since a recruitment maneuver transiently increases right ventricular afterload there is a possibility not all patients will tolerate the recruitment maneuver as described above. As per clinical practice the level of airway pressures during recruitment will be adjusted when needed to avoid adverse effects.

Discontinuation of the intervention:

In order to minimize harm the following set criteria will be used to discontinue prone position:

  • Hemodynamic instability with increased Norepinephrine >0.7mcg/kg/min
  • Sustained arrythmia which requires treatment including DC conversion
  • Any condition which, in the judgement of the investigator, might increase risk of harm to the patient

Blinding:

After allocation to supine or prone position neither the investigator, nor ordinary ICU personnel, will be blinded due to safety and impracticalities. Patients are blinded due to being under general anaesthesia during randomization until weaning from mechanical ventilation (after the study protocol is completed).

Data collection:

A site investigator will record data using a software developed by Getinge from the respirator to a designated research computer. All other data and variables, mentioned above, will be collected from the participants digital chart and real time monitoring (Philips IntelliVue \& BD Hemosphere).

Data management:

Collected data is pseudonymized and stored on a password protected designated research computer. Only authorized study personnel have access to the computer.

Original records, including signed written consent, are kept with strict confidence. These records will be kept in a secure, locked and limited access location at Sahlgrenska Univeristy Hospital during the study and after completion for an additional 10 years. At inclusion each patient is pseudonymized by receiving a participant ID, which is used in all data files.

Being tested
Prone position
Medical subject headings
Pulmonary Atelectasis, Heart Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Prone positionProcedure or surgery

    Prone position is applied in the intervention group immediately after randomization, patients will be prone for a total of 2 hours and 15 minutes. During this time 3 data collection points occur (t1, t2 \& t3).

Study groups in NCT07632027
Study groupRoleWhat they receive
Supine positionNo interventionControl group. Will remain in supine position for the whole protocol.
Prone positionExperimentalWill be turned to prone position after baseline data collection (0) and return to supine position before the final data collection (t4).
Receives: Procedure: Prone position

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiac Index

    L/min/m2

    Measured: 1 hour after baseline

Secondary outcomes (16)
  1. PVRi

    Difference between and within groups

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  2. Cardiac Index

    Difference between and within groups

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  3. RV pressure

    Looking at differences of right ventricular blood pressure between groups at all timepoints

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  4. Driving Pressure

    Plateau Pressure - PEEP

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  5. PaO2:FiO2

    Within and between groups

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  6. Vasopressor dose

    Difference of actual vasopressor dose within and between groups at all timepoints

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  7. Inotrope dose

    Difference of actual inotrope dose between groups at all timepoints

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  8. CVP

    Difference in central venous pressure within and between groups at all timepoints

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  9. PAP

    Difference in pulmonary artery pressure within and between groups at all timepoints

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  10. PCWP

    Difference in pulmonary capillary wedge pressure within and between groups at all timepoints

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  11. Systemic blood pressure

    Difference in systemic blood pressure within and between groups at all timepoints

    Measured: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  12. Heart rate

    Difference in heart rate within and between groups at all timepoints

    Measured: 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.

  13. Chest drain output

    Total amount from all chest drains between Baseline and t4.

    Measured: 2 hours 45 minutes after baseline

  14. ICU length of stay

    Time from start to end of the ICU visit, measured in days.

    Measured: Perioperative

  15. Time to extubation

    Time from arrival to the ICU until patient's endotracheal tube is removed (extubation). Measured in hours.

    Measured: Perioperative

  16. Harms

    Adverse events. Severity graded: Mild, Moderate, Severe \& Life-Threatening. Causality: Due to prone position? Other reason?

    Measured: At any point in time from Baseline to 2 hours and 45 minutes after Baseline.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionMay 2029 (estimated)
  4. Study completionOct 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07632027
Sponsor's protocol ID
286380
Acronym
BAROLO
Status last verified
Oct 2026
First submitted
24 Mar 2026
Last updated
23 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: As of now there aren't any plans to share IPD. However if good ideas for further studies on this data by other researchers appear, our plan to share IPD might change.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in